These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 7471144)
1. [Survival of 51Cr homologous platelets and HLA compatibility (author's transl)]. Fortýnová J; Májský A; Vopatová M Cas Lek Cesk; 1980 Sep; 119(38):1023-9. PubMed ID: 7471144 [No Abstract] [Full Text] [Related]
2. [HLA compatibility and survival of 51 chromium-labeled allogeneic thrombocytes]. Májský A; Fortýnová J; Vopatová M Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(6):831-7. PubMed ID: 6176508 [TBL] [Abstract][Full Text] [Related]
3. [Factors affecting the recovery rate and survival time of infused platelets (author's transl)]. Baba M Nihon Ketsueki Gakkai Zasshi; 1979 Jun; 42(3):442-52. PubMed ID: 291271 [No Abstract] [Full Text] [Related]
4. The transfusion of HLA-matched platelets to thrombocytopenic patients resistant to random donor platelets. Levy L; Woodfield DG N Z Med J; 1984 Oct; 97(766):719-21. PubMed ID: 6595558 [TBL] [Abstract][Full Text] [Related]
5. [Platelet and granulocyte transfusion and HLA (author's transl)]. Juji T Rinsho Byori; 1978 Oct; 26(10):856-60. PubMed ID: 713087 [No Abstract] [Full Text] [Related]
6. [The study of platelet kinetics with 51Cr labeled platelets (author's transl)]. Rosenblit MD Rev Bras Pesqui Med Biol; 1976; 9(1):45-53. PubMed ID: 945594 [TBL] [Abstract][Full Text] [Related]
7. Prevention of platelet refractoriness due to HLA antibodies by administration of leukocyte-poor blood components. Eernisse JG; Brand A Exp Hematol; 1981 Jan; 9(1):77-83. PubMed ID: 7238644 [TBL] [Abstract][Full Text] [Related]
8. Platelet antibodies: their detection and significance. Harmon JA; Miller WV Am J Med Technol; 1981 Oct; 47(10):797-802. PubMed ID: 7036742 [No Abstract] [Full Text] [Related]
9. [The hematological and immunological effects of platelet concentrate transfusions on surgical patients in platelet depleted states]. Umeki Y Masui; 1985 Jun; 34(6):846-60. PubMed ID: 4032712 [No Abstract] [Full Text] [Related]
10. Platelet alloimmunization after long-term red cell transfusion in transfusion-dependent thalassemia patients. Lo SC; Chang JS; Lin SW; Lin DT Transfusion; 2005 May; 45(5):761-5. PubMed ID: 15847666 [TBL] [Abstract][Full Text] [Related]
11. The clot: platelet transfusion. Chapman R Rocky Mt Med J; 1977; 74(3):146-50. PubMed ID: 301288 [No Abstract] [Full Text] [Related]
12. Variable expression of w4 and w6 on platelets: possible relevance to platelet transfusion therapy of alloimmunized thrombocytopenic patients. Duquesnoy RJ; Testin J; Aster RH Transplant Proc; 1977 Dec; 9(4):1829-31. PubMed ID: 601844 [No Abstract] [Full Text] [Related]
14. [Factors influencing transfused platelet recovery and survival, especially antiplatelet antibody (author's transl)]. Shimoyama M; Ohkura H; Minato K; Inoue K; Takenaka T Rinsho Ketsueki; 1977 Jul; 18(7):868-75. PubMed ID: 916216 [No Abstract] [Full Text] [Related]
15. The role of alloimmunization in platelet survival studies. Mueller-Eckhardt G; Breidenbach M; Mahn I; Mueller-Eckhardt C Blut; 1980 Aug; 41(2):93-9. PubMed ID: 7437528 [TBL] [Abstract][Full Text] [Related]